Role of Renin-Angiotensin System in Acute Lung Injury Caused by Viral Infection

被引:33
作者
Gao, Yan-Lei [1 ]
Du, Yue [1 ]
Zhang, Chao [1 ]
Cheng, Cheng [1 ]
Yang, Hai-Yan [1 ]
Jin, Yue-Fei [1 ]
Duan, Guang-Cai [1 ]
Chen, Shuai-Yin [1 ]
机构
[1] Zhengzhou Univ, Coll Publ Hlth, Dept Epidemiol, Zhengzhou, Henan, Peoples R China
来源
INFECTION AND DRUG RESISTANCE | 2020年 / 13卷
关键词
renin angiotensin system; acute lung injury and acute respiratory distress syndrome; viral infection; II RECEPTOR BLOCKER; CONVERTING ENZYME-2; CORONAVIRUS; ACE2; EXPRESSION; SARS-COV-2; MORTALITY; COVID-19; SUSCEPTIBILITY; EPIDEMIOLOGY;
D O I
10.2147/IDR.S265718
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The renin-angiotensin system (RAS) is the most important regulatory system of electrolyte homeostasis and blood pressure and acts through angiotensin-converting enzyme (ACE)/angiotensin II (Ang II)/Ang II type 1 (AT1) receptor axis and angiotensin-converting enzyme 2 (ACE2)/angiotensin (1-7)/MAS receptor axis. RAS dysfunction is related to the occurrence and development of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) and causes a serious prognosis and even death. ALI/ARDS can be induced by various ways, one of which is viral infections, such as SARS-CoV, SARS-CoV-2, H5N1, H7N9, and EV71. This article reviews the specific mechanism on how RAS dysfunction affects ALI/ARDs caused by viral infections. SARS-CoV and SARS-CoV-2 enter the host cells by binding with ACE2. H5N1 and H7N9 avian influenza viruses reduce the ACE2 level in the body, and EV71 increases Ang II concentration. Treatment with angiotensin-converting enzyme inhibitor and angiotensin AT1 receptor blocker can alleviate ALI/ARDS symptoms. This review provides suggestions for the treatment of lung injury caused by viral infections.
引用
收藏
页码:3715 / 3725
页数:11
相关论文
共 106 条
  • [1] Abdul-Hafez A, 2018, J LUNG PULM RESP RES, V5
  • [2] Agrawal Vimal, 2016, Indian Heart J, V68, P856, DOI 10.1016/j.ihj.2016.06.010
  • [3] Renin-angiotensin-aldosterone system and COVID-19 infection
    Alexandre, Joachim
    Cracowski, Jean-Luc
    Richard, Vincent
    Bouhanick, Beatrice
    [J]. ANNALES D ENDOCRINOLOGIE, 2020, 81 (2-3) : 63 - 67
  • [4] [Anonymous], 2015, ARTERIOSCL THROM VAS, DOI [10.1038/s41586-022-05363-z, DOI 10.1038/s41586-020-2012-7]
  • [5] [Anonymous], 2020, AM J RESP CRIT CARE, DOI [10.1164/rccm.202001-0179LE, DOI 10.1164/rccm.202001-0179LE]
  • [6] [Anonymous], 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)30211-7
  • [7] THE ANGIOTENSIN-CONVERTING ENZYME INHIBITOR CAPTOPRIL INHIBITS POLY(ADP-RIBOSE) POLYMERASE ACTIVATION AND EXERTS BENEFICIAL EFFECTS IN AN OVINE MODEL OF BURN AND SMOKE INJURY
    Asmussen, Sven
    Bartha, Eva
    Olah, Gabor
    Sbrana, Elena
    Rehberg, Sebastian W.
    Yamamoto, Yusuke
    Enkhbaatar, Perenlei
    Hawkins, Hal K.
    Ito, Hiroshi
    Cox, Robert A.
    Traber, Lillian D.
    Traber, Daniel L.
    Szabo, Csaba
    [J]. SHOCK, 2011, 36 (04): : 402 - 409
  • [8] Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severeCOVID-19infection in a multi-siteUKacute hospital trust
    Bean, Daniel M.
    Kraljevic, Zeljko
    Searle, Thomas
    Bendayan, Rebecca
    Kevin, O'Gallagher
    Pickles, Andrew
    Folarin, Amos
    Roguski, Lukasz
    Noor, Kawsar
    Shek, Anthony
    Zakeri, Rosita
    Shah, Ajay M.
    Teo, James T. H.
    Dobson, Richard J. B.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (06) : 967 - 974
  • [9] Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries
    Bellani, Giacomo
    Laffey, John G.
    Pham, Tai
    Fan, Eddy
    Brochard, Laurent
    Esteban, Andres
    Gattinoni, Luciano
    van Haren, Frank
    Larsson, Anders
    McAuley, Daniel F.
    Ranieri, Marco
    Rubenfeld, Gordon
    Thompson, B. Taylor
    Wrigge, Hermann
    Slutsky, Arthur S.
    Pesenti, Antonio
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (08): : 788 - 800
  • [10] Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection
    Bian, Jingwei
    Zhao, Rongsheng
    Zhai, Suodi
    Li, Zijian
    [J]. ACTA PHARMACEUTICA SINICA B, 2020, 10 (07) : 1251 - 1252